Kiniksa Pharmaceuticals International Plc (KNSA)

May 05, 2025

Kiniksa Pharmaceuticals: Making Steady Progress (NASDAQ:KNSA) - Seeking Alpha

May 05, 2025

May 02, 2025

Insider’s View: Deciphering Kiniksa Pharmaceuticals International Plc (KNSA)’s Financial Health Through Ratios - DWinneX

May 02, 2025

May 02, 2025

How should investors view Kiniksa Pharmaceuticals International Plc (KNSA)? - uspostnews.com

May 02, 2025

May 02, 2025

Kiniksa Pharmaceuticals International Insider Sold Shares Worth $2,265,339, According to a Recent SEC Filing - marketscreener.com

May 02, 2025

May 01, 2025

Kiniksa Pharmaceuticals Executives Sell Shares - TradingView

May 01, 2025

May 01, 2025

Wall Street analysts’ outlook for Kiniksa Pharmaceuticals International Plc (KNSA) - Sete News

May 01, 2025

May 01, 2025

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2025 Earnings Call Transcript - Insider Monkey

May 01, 2025

May 01, 2025

3 Stocks Including Kiniksa Pharmaceuticals International That May Be Priced Below Intrinsic Value Estimates - Yahoo Finance

May 01, 2025

May 01, 2025

Kiniksa Pharmaceuticals International PLC (KNSA) Q1 2025: Everyt - GuruFocus

May 01, 2025

Apr 30, 2025

Examining the Potential Price Growth of Kiniksa Pharmaceuticals International Plc (KNSA) - knoxdaily.com

Apr 30, 2025

Apr 30, 2025

Kiniksa (KNSA) Partners with Carly Pearce for Health Awareness C - GuruFocus

Apr 30, 2025

Apr 30, 2025

Kiniksa Pharmaceuticals International Plc (KNSA) Stock: A Year of Decreases and Increases - investchronicle.com

Apr 30, 2025

Apr 30, 2025

Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis - GlobeNewswire

Apr 30, 2025

Apr 30, 2025

Country Star Carly Pearce Opens Up About 4-Year Struggle With Rare Heart Disease in New Campaign - Stock Titan

Apr 30, 2025

Apr 30, 2025

An Intrinsic Calculation For Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Suggests It's 41% Undervalued - Yahoo Finance

Apr 30, 2025

Apr 30, 2025

Kiniksa raises ARCALYST 2025 revenue guidance to $605M amid strong Q1 performance - MSN

Apr 30, 2025

Apr 30, 2025

Decoding Kiniksa Pharmaceuticals International PLC (KNSA): A Str - GuruFocus

Apr 30, 2025

Apr 29, 2025

Wedbush Raises Price Target on Kiniksa Pharmaceuticals to $36 From $34, Maintains Outperform Rating - marketscreener.com

Apr 29, 2025

Apr 29, 2025

Kiniksa Pharmaceuticals: A Biotech Stock on the Rise, But What’s Next? - RagingBull

Apr 29, 2025

Apr 29, 2025

Kiniksa Pharmaceuticals International, plc Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

Apr 29, 2025

Apr 29, 2025

Kiniksa Pharmaceuticals Surpasses Q1 2025 Revenue Estimates with $137.8 Million, EPS Details Unavailable - GuruFocus

Apr 29, 2025

Apr 29, 2025

Kiniksa Pharmaceuticals Reports First Quarter 2025 Financial Res - GuruFocus

Apr 29, 2025

Apr 29, 2025

Kiniksa Pharmaceuticals Swings to Q1 Net Income, Revenue Increases - marketscreener.com

Apr 29, 2025

Apr 29, 2025

KNSA: Kiniksa Forecasts Increased ARCALYST Revenue for 2025 | KN - GuruFocus

Apr 29, 2025

Apr 29, 2025

Kiniksa Pharmaceuticals Reports First Quarter 2025 Financial Results and Recent Portfolio Execution - The Manila Times

Apr 29, 2025

Apr 29, 2025

Kiniksa Pharmaceuticals Reports First Quarter 2025 Financial Results - TradingView

Apr 29, 2025

Apr 29, 2025

Kiniksa Q1 Earnings: ARCALYST Revenue Soars 75% to $138M, 2025 Guidance Boosted to $605M - Stock Titan

Apr 29, 2025

Apr 28, 2025

Examining the Future: Kiniksa Pharmaceuticals's Earnings Outlook - Benzinga

Apr 28, 2025

Apr 24, 2025

Kiniksa Pharmaceuticals to Report First Quarter 2025 Financial Results on April 29, 2025 - GlobeNewswire

Apr 24, 2025

Apr 24, 2025

Kiniksa Pharmaceuticals Sets Q1 2025 Earnings Call Date: How to Access Live Results and Portfolio Updates - Stock Titan

Apr 24, 2025

Apr 24, 2025

Its Stock Has Paid Off Big Time For Kiniksa Pharmaceuticals International Plc - Sete News

Apr 24, 2025

Apr 24, 2025

Kiniksa Pharmaceuticals introduces new incentive plan By Investing.com - Investing.com India

Apr 24, 2025

Apr 23, 2025

Kiniksa Pharmaceuticals introduces new incentive plan - Investing.com Australia

Apr 23, 2025

Apr 23, 2025

Kiniksa Pharmaceuticals chief commercial officer sells $370,475 in stock By Investing.com - Investing.com South Africa

Apr 23, 2025

Apr 23, 2025

Kiniksa Pharmaceuticals chief commercial officer sells $370,475 in stock - Investing.com Australia

Apr 23, 2025

Apr 23, 2025

Lacklustre Performance Is Driving Kiniksa Pharmaceuticals International, plc's (NASDAQ:KNSA) Low P/S - simplywall.st

Apr 23, 2025

Apr 21, 2025

SEC Form DEFA14A filed by Kiniksa Pharmaceuticals International plc - Quantisnow

Apr 21, 2025

Apr 10, 2025

Analysts Set Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) PT at $37.17 - Defense World

Apr 10, 2025

Mar 29, 2025

KNSA Stock Sees Decline of Approximately -1.89% in Last Five Days - knoxdaily.com

Mar 29, 2025

Mar 24, 2025

Kiniksa CFO Mark Ragosa sells shares worth $368,465 By Investing.com - Investing.com South Africa

Mar 24, 2025

Mar 24, 2025

Kiniksa CFO Mark Ragosa sells shares worth $368,465 - Investing.com India

Mar 24, 2025

Mar 22, 2025

Kiniksa Pharmaceuticals International PLC (KNSA) Shares Down 1.8 - GuruFocus

Mar 22, 2025

Mar 19, 2025

Kiniksa pharmaceuticals CFO Mark Ragosa sells $469,923 in stock By Investing.com - Investing.com South Africa

Mar 19, 2025

Mar 19, 2025

Kiniksa pharmaceuticals CFO Mark Ragosa sells $469,923 in stock - Investing.com

Mar 19, 2025

Mar 18, 2025

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Earns Buy Rating from Analysts at Citigroup - MarketBeat

Mar 18, 2025

Mar 17, 2025

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) CAO Michael R. Megna Sells 9,051 Shares - MarketBeat

Mar 17, 2025

Mar 17, 2025

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Receives $36.60 Average Target Price from Analysts - MarketBeat

Mar 17, 2025

Mar 17, 2025

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) CFO Sells $809,277.00 in Stock - MarketBeat

Mar 17, 2025

Mar 16, 2025

Globeflex Capital L P Boosts Holdings in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) - MarketBeat

Mar 16, 2025

Mar 16, 2025

Connor Clark & Lunn Investment Management Ltd. Sells 17,118 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) - MarketBeat

Mar 16, 2025